Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial).

@article{Green2015RelationOF,
  title={Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial).},
  author={Philip Paige Green and Suzanne V Arnold and David Jacques Cohen and Ajay J. Kirtane and Susheel K. Kodali and David L. Brown and Charanjit S. Rihal and Ke Xu and Yang Lei and Marian C Hawkey and Rebeca J Kim and Maria C Alu and Martin B. Leon and Michael J. Mack},
  journal={The American journal of cardiology},
  year={2015},
  volume={116 2},
  pages={264-9}
}
Transcatheter aortic valve replacement (TAVR) is an effective treatment for severe symptomatic aortic stenosis (AS) in patients who are inoperable or at high risk for surgery. However, the intermediate- to long-term mortality is high, emphasizing the importance of patient selection. We, therefore, sought to evaluate the prognostic value of frailty in older recipients of TAVR, hypothesizing that frail patients would experience a higher mortality rate and a higher likelihood of poor outcome 1… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 36 extracted citations

Similar Papers

Loading similar papers…